洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

【ChiCTR2000032336】IS PREDICTION OF LOCAL RECURRENCE POSSIBLE IN PAGET’S DISEASE OF THE BREAST?

基本信息
登记号

ChiCTR2000032336

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2020-04-26

临床申请受理号

/

靶点

/

适应症

Mammary Paget'S disease

试验通俗题目

IS PREDICTION OF LOCAL RECURRENCE POSSIBLE IN PAGET’S DISEASE OF THE BREAST?

试验专业题目

IS PREDICTION OF LOCAL RECURRENCE POSSIBLE IN PAGET’S DISEASE OF THE BREAST?

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

Mammary Paget disease of the breast is rare form of breast cancer. Recent trends in the management has changed from mastectomy to breast conserving surgery, its safety is still controversial. The study aimed to predict the patients prone to local recurrence, and to find out the answer to the question of who should be a candidate for breast conserving surgery.

试验分类
请登录查看
试验类型

队列研究

试验分期

回顾性研究

随机化

non randomized

盲法

None

试验项目经费来源

own funding

试验范围

/

目标入组人数

69

实际入组人数

/

第一例入组时间

2020-04-25

试验终止时间

2020-04-25

是否属于一致性

/

入选标准

Between January 2007 and December 2017, an institutional database search was done retrospectively to select patients with a diagnosis of mammary PD and underwent surgery in our hospital. Sixty nine women operated for a stage I to III breast cancer were enrolled in this study;

排除标准

Eleven patients with a synchronous other primary malignancy or who did not come to regular follow-up, were excluded.;

研究者信息
研究负责人姓名
请登录查看
试验机构

SBU, Ankara Oncology Education and Research Hospital

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

SBU, Ankara Oncology Education and Research Hospital的其他临床试验

土耳其安卡拉肿瘤学教育和研究医院的其他临床试验

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用